Delhivery Limited has announced a facility visit for investors at its Lonad Mega Gateway in Bhiwandi, Maharashtra, scheduled for April 08, 2026. The company has formally notified both BSE Limited and National Stock Exchange of India Limited about this event in compliance with regulatory requirements.

Regulatory Compliance and Notification

The announcement was made pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. Company Secretary and Compliance Officer Madhulika Rawat signed the notification on March 12, 2026, ensuring proper disclosure to stock exchanges.

Facility Visit Details

The visit is designed as a facility tour where investors will receive an overview of facility operations and related operational aspects. Delhivery has specifically clarified that this will be solely a facility visit focused on operational demonstrations and facility walkthroughs.

The company has emphasized its commitment to regulatory compliance by stating that no unpublished price-sensitive information (UPSI) will be disclosed during the visit that is not already available in the public domain. This ensures adherence to insider trading regulations and maintains transparency standards.

Corporate Information and Disclosure

Delhivery Limited operates from its corporate office located at Plot 5, Sector 44, Gurugram, Haryana, with its registered office situated at the Air Cargo Logistics Centre-II near IGI Airport, New Delhi. The company has made this disclosure available on its official website at www.delhivery.com for broader stakeholder access.

The notification was digitally signed by Madhulika Rawat, who serves as Company Secretary and Compliance Officer with membership number F8765, ensuring proper authentication and regulatory compliance for the facility visit announcement.

Delhivery Limited has announced the allotment of 85,052 equity shares following the exercise of vested options under its Employee Stock Option Plan 2012 (ESOP 2012). The Stakeholders' Relationship Committee approved this allotment on March 09, 2026, in compliance with SEBI Listing Regulations.

Share Capital Enhancement

The allotment has resulted in a notable increase in the company's paid-up share capital. The newly issued equity shares carry a face value of Re. 1 each and are fully paid-up, ranking pari-passu with existing equity shares in all respects.

ESOP Exercise Details

The options exercised under ESOP 2012 were granted at different pricing levels, reflecting the company's historical stock option grants. The exercise demonstrates employee confidence in the company's long-term prospects.

Financial Impact

The share allotment has implications for the company's earnings metrics. Based on Q3FY26 earnings, the diluted earnings per share following this allotment stands at Re. 0.99. The options were exercised in accordance with the vesting schedule determined by the Nomination and Remuneration Committee.

Regulatory Compliance

The ESOP scheme operates in full compliance with SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021. The newly allotted shares are not subject to any lock-in restrictions and will be available for trading immediately. The company has fulfilled all disclosure requirements under Regulation 30 of SEBI Listing Regulations, with detailed information provided to both BSE and NSE.

The vested options could be exercised at any time from their respective vesting dates as per the grant terms, providing flexibility to employees in timing their exercise decisions.